Sachiko Hirobe

1.1k total citations
27 papers, 847 citations indexed

About

Sachiko Hirobe is a scholar working on Pharmaceutical Science, Dermatology and Immunology. According to data from OpenAlex, Sachiko Hirobe has authored 27 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 12 papers in Dermatology and 10 papers in Immunology. Recurrent topics in Sachiko Hirobe's work include Advancements in Transdermal Drug Delivery (16 papers), Dermatology and Skin Diseases (10 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Sachiko Hirobe is often cited by papers focused on Advancements in Transdermal Drug Delivery (16 papers), Dermatology and Skin Diseases (10 papers) and Toxin Mechanisms and Immunotoxins (6 papers). Sachiko Hirobe collaborates with scholars based in Japan and United States. Sachiko Hirobe's co-authors include Naoki Okada, Shinsaku Nakagawa, Ying-Shu Quan, Fumio Kamiyama, Kazuhiko Matsuo, Hiroaki Azukizawa, Ichiro Katayama, Takaaki Hanafusa, Hideo Asada and Takeshi Nakagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Sachiko Hirobe

27 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sachiko Hirobe Japan 15 643 427 260 124 102 27 847
Haripriya Kalluri United States 13 747 1.2× 466 1.1× 195 0.8× 144 1.2× 97 1.0× 13 870
Leonard Y. Chu United States 5 567 0.9× 318 0.7× 158 0.6× 127 1.0× 110 1.1× 6 711
Aoife M. Rodgers United Kingdom 14 370 0.6× 161 0.4× 104 0.4× 180 1.5× 62 0.6× 23 672
Yasmine Gomaa Egypt 12 387 0.6× 222 0.5× 83 0.3× 99 0.8× 51 0.5× 13 519
Mara Leone Netherlands 8 394 0.6× 217 0.5× 140 0.5× 98 0.8× 73 0.7× 9 454
Eva M. Vicente‐Pérez United Kingdom 10 1.2k 1.9× 661 1.5× 155 0.6× 167 1.3× 247 2.4× 10 1.3k
Peipei Yang China 9 329 0.5× 202 0.5× 132 0.5× 158 1.3× 58 0.6× 12 654
Desmond I. J. Morrow United Kingdom 19 1.6k 2.5× 990 2.3× 239 0.9× 230 1.9× 259 2.5× 26 1.9k
Oksana Lyubomska United Kingdom 7 199 0.3× 109 0.3× 220 0.8× 119 1.0× 30 0.3× 8 445
Rikhav P. Gala United States 12 203 0.3× 64 0.1× 126 0.5× 93 0.8× 33 0.3× 17 426

Countries citing papers authored by Sachiko Hirobe

Since Specialization
Citations

This map shows the geographic impact of Sachiko Hirobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sachiko Hirobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sachiko Hirobe more than expected).

Fields of papers citing papers by Sachiko Hirobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sachiko Hirobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sachiko Hirobe. The network helps show where Sachiko Hirobe may publish in the future.

Co-authorship network of co-authors of Sachiko Hirobe

This figure shows the co-authorship network connecting the top 25 collaborators of Sachiko Hirobe. A scholar is included among the top collaborators of Sachiko Hirobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sachiko Hirobe. Sachiko Hirobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hata, Keiko, et al.. (2024). Infusion-Related Reactions Subsequent to Avelumab, Durvalumab, and Atezolizumab Administration: A Retrospective Observational Study. SHILAP Revista de lepidopterología. 14(2). 377–387. 1 indexed citations
2.
Hirobe, Sachiko, et al.. (2022). Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells. Pharmaceutics. 14(2). 385–385. 4 indexed citations
3.
Hirobe, Sachiko, et al.. (2022). The Effects of Chimeric Antigen Receptor (CAR) Hinge Domain Post-Translational Modifications on CAR-T Cell Activity. International Journal of Molecular Sciences. 23(7). 4056–4056. 13 indexed citations
4.
5.
6.
Hirobe, Sachiko, et al.. (2021). Characteristics of immune induction by transcutaneous vaccination using dissolving microneedle patches in mice. International Journal of Pharmaceutics. 601. 120563–120563. 9 indexed citations
7.
Shioyama, Wataru, Takuya Shintani, Shinichiro Maeda, et al.. (2021). Vascular Endothelial Growth Factor Receptor Inhibitors Impair Left Ventricular Diastolic Functions. International Heart Journal. 62(6). 1297–1304. 3 indexed citations
8.
Hirobe, Sachiko, Ying-Shu Quan, Fumio Kamiyama, et al.. (2020). Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant. Pharmaceutics. 12(3). 267–267. 14 indexed citations
9.
Hirobe, Sachiko, Mizuho Nagao, Ying-Shu Quan, et al.. (2020). Immunogenicity of Milk Protein-Containing Hydrophilic Gel Patch for Epicutaneous Immunotherapy for Milk Allergy. Pharmaceutical Research. 37(3). 35–35. 14 indexed citations
10.
Ohno, Masako, Shinpei Nonen, Sachiko Hirobe, et al.. (2019). Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients. European Journal of Clinical Pharmacology. 75(7). 901–911. 7 indexed citations
11.
Hirobe, Sachiko, Hiroshi Iioka, Ying-Shu Quan, et al.. (2016). Clinical study of a retinoic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo. Life Sciences. 168. 24–27. 27 indexed citations
12.
Hirobe, Sachiko, et al.. (2016). Highly efficient gene transfer using a retroviral vector into murine T cells for preclinical chimeric antigen receptor-expressing T cell therapy. Biochemical and Biophysical Research Communications. 473(1). 73–79. 17 indexed citations
13.
Hirobe, Sachiko, Hiroaki Azukizawa, Takaaki Hanafusa, et al.. (2015). Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials. 57. 50–58. 185 indexed citations
14.
Hirobe, Sachiko, Naoki Okada, & Shinsaku Nakagawa. (2013). Transcutaneous vaccines – current and emerging strategies. Expert Opinion on Drug Delivery. 10(4). 485–498. 20 indexed citations
15.
Hirobe, Sachiko, Hiroshi Iioka, Ying-Shu Quan, et al.. (2013). Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans. Journal of Controlled Release. 171(2). 93–103. 35 indexed citations
16.
Matsuo, Kazuhiko, Sachiko Hirobe, Naoki Okada, & Shinsaku Nakagawa. (2013). Frontiers of transcutaneous vaccination systems: Novel technologies and devices for vaccine delivery. Vaccine. 31(19). 2403–2415. 45 indexed citations
17.
Hirobe, Sachiko, Hiroaki Azukizawa, Kazuhiko Matsuo, et al.. (2013). Development and Clinical Study of a Self-Dissolving Microneedle Patch for Transcutaneous Immunization Device. Pharmaceutical Research. 30(10). 2664–2674. 87 indexed citations
18.
Matsuo, Kazuhiko, Yumiko Ishii, Yasuaki Kawai, et al.. (2013). Analysis of Transcutaneous Antigenic Protein Delivery by a Hydrogel Patch Formulation. Journal of Pharmaceutical Sciences. 102(6). 1936–1947. 12 indexed citations
19.
Hirobe, Sachiko, Kazuhiko Matsuo, Ying-Shu Quan, et al.. (2012). Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria. Vaccine. 30(10). 1847–1854. 26 indexed citations
20.
Nakagawa, Takeshi, Ying-Shu Quan, Fumio Kamiyama, et al.. (2012). Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system. International Journal of Pharmaceutics. 441(1-2). 570–579. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haripriya Kalluri Breakdown of academic impact, for papers by Leonard Y. Chu Breakdown of academic impact, for papers by Aoife M. Rodgers Breakdown of academic impact, for papers by Yasmine Gomaa Breakdown of academic impact, for papers by Mara Leone Breakdown of academic impact, for papers by Eva M. Vicente‐Pérez Breakdown of academic impact, for papers by Peipei Yang Breakdown of academic impact, for papers by Desmond I. J. Morrow Breakdown of academic impact, for papers by Oksana Lyubomska Breakdown of academic impact, for papers by Rikhav P. Gala
Rankless by CCL
2026